Overview: Galactosemia Screen TestIntroduction: The Galactosemia Screen Test screens for galactosemia to detect enzyme deficiencies, preventing liver damage or developmental delays. Following 2023 AAP guidelines, it uses PCR for high sensitivity, aiding in metabolic screening. This test is critical for early detection and improving outcomes in molecular pathology for patients with suspected galactosemia.
Other Names: Galactosemia Screening Assay, Metabolic Disorder Screen.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Galactosemia screening began in the 1960s with newborn screening programs. PCR-based assays emerged in the 2000s, improving sensitivity.
Purpose: Screens for galactosemia, prevents complications, and monitors enzyme deficiencies in patients at risk for liver damage or developmental delays.
Test Parameters: 1. Galactosemia Markers
Pretest Condition: No fasting required. Collect whole blood or dried blood spots at any time. Report family history of galactosemia.
Specimen: 2-5 mL whole blood (EDTA) or 3-5 dried blood spots (DBS card). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document family history of galactosemia or symptoms like liver damage or developmental delays. Include current diet.
Consent: Written consent required, detailing the tests purpose, screening implications, and potential need for dietary management.
Procedural Considerations: Uses PCR to detect galactosemia markers (e.g., GALT activity). Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper sample collection or storage can affect results. Early testing may yield false negatives.
Clinical Significance: Abnormal markers suggest galactosemia, prompting confirmatory testing. Normal results may require further screening.
Specialist Consultation: Consult a pediatrician or metabolic specialist for result interpretation.
Additional Supporting Tests: GALT mutation test, galactose test, or newborn screening to confirm galactosemia.
Test Limitations: False negatives may occur in early stages. Results require clinical correlation.
References: AAP Galactosemia Guidelines, 2023; Pediatrics, Berry GT, 2022.
